Gyomor- és nyelőcsőrák: vizsgálatok itt: Hollandia
58 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Amsterdam, Maastricht, Zwolle
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 3. fázisTaking peopleA Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Where
- Leeuwarden, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT06901531 · EU 2024-519773-19-00 - 1. fázisTaking peoplePhase 1 Study of PF-08046033 in Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Pfizer
See details and how to joinNCT07519655 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Amsterdam, Maastricht, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 1/2. fázisTaking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - No phaseTaking people"Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project.
- Where
- Amsterdam
- People
- 3156
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06803147 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 3. fázisTaking peopleA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Where
- Amsterdam, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 510 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644781 · EU 2023-509630-19-00 - 2. fázisTaking peoplePan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 153
- Run by
- Netherlands Cancer Institute
See details and how to joinNCT06279130 · EU 2023-505756-21-00 - 2. fázisTaking peopleINTERACT Stomach-II
- Where
- Amsterdam, Eindhoven, Rotterdam
- People
- 55
- Run by
- Erasmus Medical Center
See details and how to joinNCT07133490 · EU 2025-521468-36-00 - 3. fázisTaking peopleA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- Where
- Amsterdam, Arnhem, Leiden
- Életkor
- 18 év and over
- People
- 840 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06764875 · EU 2024-512583-57-00 - 3. fázisTaking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Amsterdam, Groningen, Rotterdam, Tilburg
- Életkor
- 18 év and over
- People
- 2130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 2. fázisTaking people[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Groningen, Nijmegen
- Életkor
- 18 év to 79 év
- People
- 71 worldwide
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07702292 · EU 2025-521983-36-00 - No phaseTaking peopleDetection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 63
- Run by
- Erasmus Medical Center
See details and how to joinNCT06308510 - 2. fázisTaking peopleTiming of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
- Where
- Amsterdam, Utrecht
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07000253 - 1. fázisTaking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - 3. fázisTaking peopleThe IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients with Peritoneal Metastasis
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2024-514879-17-00 - 3. fázisTaking peopleTrial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab in First-line Metastatic HER2-positive Gastric or GEJ Cancer
- Where
- Amsterdam, Leeuwarden, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 228 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-513122-27-00 - 1/2. fázisTaking peopleA Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 15
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT05701176 · EU 2024-517960-45-00 - 2/3. fázisTaking peopleAssessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 34
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06457789 · EU 2023-509486-20-00 - 3. fázisTaking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Amsterdam, Leeuwarden, Nijmegen, Rotterdam, Tilburg, Utrecht
- Életkor
- 18 év and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00